Navigation Links
IR BioSciences Announces Promising Data from Study of Its Compound,Homspera

As the World Health Organization notes, when the next pandemic virus strain emerges, it could circle the globe in three months and cause significant morbidity and mortality. Subsequent waves of virus spread would add to the economic and social dislocation. Whatever drugs or vaccines are available at the start of the pandemic must be sufficient to vaccinate or treat the maximum number of people within weeks or at most, a few months. Adjuvants provide the capability to maximize the number of individuals who can be treated with a limited amount of vaccine.

In conjunction with Homspera's previously reported capability to decrease influenza viral titers and symptoms in the cotton rat model of influenza, the adjuvant capability makes Homspera a highly desirable candidate product for use in influenza. ImmuneRegen BioSciences will continue to explore this capability of its Homspera compound.

About ImmuneRegen BioSciences, Inc.

IR BioSciences Holdings Inc., through its wholly owned subsidiary ImmuneRegen BioSciences, Inc., is a development stage biotechnology company focused on the research and development of Homspera(TM) and its derivatives Radilex(TM) and Viprovex(TM), which are designed to be used as countermeasures for multiple homeland security bioterrorism threats. Homspera is derived from modified Substance P, a naturally occurring peptide immunomodulator and homeostatic compound with the dual effect of improving pulmonary function and the stimulation of the human immune system. For more information, please visit the company's website at www.immuneregen.com.

Statements about the Company's future expectations, including statements about the potential for the Company's drug candidates, science and technology, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Sec
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:7/28/2015)... 2015  Express Scripts Holding Company (Nasdaq: ESRX ... Express Scripts stockholders of $600.1 million, or $0.88 per ... in Table 4, were $1.44 for the second quarter. ... companies across healthcare are validating the need for size ... Officer. "But, what matters most is how that size ...
(Date:7/28/2015)... SANTA MONICA, Calif. , July 28, 2015 /PRNewswire-USNewswire/ ... decline in prescription drug abuse and doctor shopping after ... database before prescribing powerful and addictive medications is yet ... Watchdog said today. Since ... the number of patients "doctor shopping" declined by 52 ...
(Date:7/28/2015)... REDMOND, Wash. , July 28, 2015 ... ingestion of Nutraceutix,s L. reuteri probiotic enriches ... factors that increase insulin secretion.  The study involved daily ... strain SD-5865) in tablets using the patented BIO- tract ... from damage by stomach acid on their way to ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
... Oct. 18 Althea Technologies, Inc., a leading ... and parenteral drug products, announced today that it ... H3-5 high-speed syringe filling line.  This line is ... facility in San Diego. The expanded capacity complements ...
... The National Association of State Controlled Substances Authorities ... Purdue Pharma L.P. today at the organization,s 27th ... is part of Purdue Pharma,s ongoing efforts to ... state prescription drug monitoring programs, which can be ...
Cached Medicine Technology:Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line 2NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs 2
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, along with Zip-Pak ... Powers is responsible for driving growth and innovation across ITW Dynatec’s worldwide customer ... as an effective leader within the ITW community speaks for itself. We are ...
(Date:7/28/2015)... , ... July 29, 2015 , ... Talking About Your ... 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , When a ... — and can’t — say about it is tightly regulated by the FDA. , ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Every July, since ... with the disease only experience through movies and television. They go to summer camp. ... the right side of the heart as it pushes hard to get blood through ...
(Date:7/28/2015)... ... 28, 2015 , ... ProFont is back with a whole new stylized and ... users can generate a hand drawn feel all with a click of a mouse. ... from either the upper and lowercase alphabet, special characters, numbers, and stylized compound tools. ...
Breaking Medicine News(10 mins):Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2
... years,since the nation,s capital was stunned by terrorist ... are we any better prepared now than we,were ... Hospital,Center will answer the question, Tuesday evening, October ... READY?" -- as they present the,Washington Hospital Center,s ...
... Renowned Therapist Challenges Modern Psychology and Explodes Myths of ,Why ... ... children have a,genetic predisposition to bad behavior and are more difficult to ... parents, has,been the cross parents have had to bear for decades, placing ...
... October 29, 2007 - A new study published in ... self-reported active epilepsy and health-related quality of life among ... data collected in the 2003 California Health Interview Survey ... finds that in 2003, almost 300,000 (1.2 percent) adults ...
... - Monthly blog will appear in conjunction with ... 29 The Kellogg School,of Management at Northwestern ... monthly blog developed by David Dranove, the Kellogg ... Management.,"Code Red" is accessible at the following link:, ...
... (Amex: PRZ ), one of the nation,s leading ... announced that at its,2007 Annual Meeting of Stockholders held ... of board members and the,ratification of Brimmer, Burek & ... ending December 31, 2007. Re-elected board members, who ...
... Pharmaceuticals,Inc., which discovers and develops novel antiviral therapeutics ... of Steven D.,Skolsky as its President and Chief ... of the Board of Directors. "Sequoia is ... as Steven Skolsky," said Chris Mirabelli, Chairman of ...
Cached Medicine News:Health News:Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Kellogg School of Management Announces 'Code Red' 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 3Health News:Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer 2
Upper arm protection...
Lap pad used to protect pelvic regions...
Light and comfortable thyroid protection. The softest, most comfortable throid collar made. No neck irritating binding....
The front of this apron is tapered for maximum adjustability as needed. We can include a specially designed half-apron to be worn under the full apron for double protection in the abdomen/pelvic cav...
Medicine Products: